The fact that cannabis has a strong medical and therapeutic potential is not new. Indeed, the question we should ask is not about if medical cannabis works: the key question is how to get the maximum therapeutic benefit from cannabis and what combination of cannabinoids is the most efficient.
The WA father and media personality-turned medical cannabis advocate is now hosting public workshops aimed at breaking down the barriers to therapeutic cannabis use. And he says his reasons for supporting the cause are as personal as they get.
Cannabis and the brain is a hot topic. For much too long, the green, leafy plant was considered to be a catalyst for mental health problems, such as schizophrenia and psychosis.
St. Louis-based BeLeaf Medical LLC opened its first cultivation center—and the first medical cannabis cultivation facility in Missouri—in Earth City last week, according to a Springfield News-Leader report.
Kansas lawmakers introduced a medical cannabis legalization bill June 3, according to a Business Insurance report.
The new strain, the only one in the cannabis market, is totally legal as it is free of psychoactive components and stands out for its big therapeutic potential in the treatment of illness as Crohn’s disease, colon cancer, glaucoma, Parkinson’s and Alzheimer’s, among others.
n increasing number of patients with rheumatoid arthritis (RA) are using cannabis to treat their symptoms, although systematic studies regarding efficacy in RA are lacking. Within this review we will give an overview on the overall effects of cannabinoids in inflammation and why they might be useful in the treatment of RA.
Most Canadian pediatricians are shying away from medical cannabis for patients, knowing that it can hurt the developing brain and that there isn’t much research to guide them.